6.97
전일 마감가:
$7.16
열려 있는:
$7.15
하루 거래량:
1.85M
Relative Volume:
1.07
시가총액:
$1.11B
수익:
$93.95M
순이익/손실:
$-129.87M
주가수익비율:
-7.7444
EPS:
-0.9
순현금흐름:
$-202.88M
1주 성능:
-15.92%
1개월 성능:
-17.51%
6개월 성능:
-35.52%
1년 성능:
+18.94%
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
WVE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
WVE
Wave Life Sciences Ltd
|
6.97 | 1.18B | 93.95M | -129.87M | -202.88M | -0.90 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-08-04 | 개시 | Canaccord Genuity | Buy |
2025-07-28 | 개시 | Oppenheimer | Outperform |
2025-07-16 | 개시 | Citigroup | Buy |
2025-06-11 | 재개 | Raymond James | Outperform |
2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
2025-04-08 | 개시 | Wedbush | Outperform |
2025-02-25 | 개시 | Jefferies | Buy |
2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-09-27 | 재개 | JP Morgan | Overweight |
2024-09-19 | 개시 | B. Riley Securities | Buy |
2024-09-09 | 개시 | JP Morgan | Overweight |
2024-05-15 | 개시 | Wells Fargo | Overweight |
2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2023-07-05 | 개시 | Raymond James | Outperform |
2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
2020-12-15 | 재개 | H.C. Wainwright | Buy |
2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | 개시 | Guggenheim | Buy |
2019-07-15 | 개시 | Cowen | Market Perform |
2019-04-17 | 재확인 | H.C. Wainwright | Buy |
2018-08-07 | 개시 | Stifel | Buy |
2018-07-23 | 개시 | H.C. Wainwright | Buy |
2018-03-19 | 재확인 | Mizuho | Buy |
2017-02-15 | 개시 | H.C. Wainwright | Buy |
2016-11-10 | 재개 | Leerink Partners | Outperform |
2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
2015-12-07 | 개시 | Jefferies | Buy |
2015-12-07 | 개시 | Leerink Partners | Outperform |
2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences is Now Oversold (WVE) - Nasdaq
FY2027 EPS Forecast for WAVE Life Sciences Lifted by Analyst - MarketBeat
WAVE Life Sciences Ltd. $WVE Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Trexquant Investment LP Trims Stake in WAVE Life Sciences Ltd. $WVE - MarketBeat
Wave Life Sciences (WVE) Sees Promising Results From RestorAATion-2 Study - simplywall.st
Invesco Ltd. Increases Stock Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences' (WVE) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Is Wave Life Sciences Ltd. the Top Chart Pick This WeekMarket Sentiment Review & Fast Momentum Stock Entry Tips - beatles.ru
Published on: 2025-09-08 19:37:33 - beatles.ru
Trendlines Converge — Decision Point for Wave Life Sciences Ltd.July 2025 Earnings & Expert Approved Trade Ideas - beatles.ru
WAVE Life Sciences (NASDAQ:WVE) Shares Gap DownTime to Sell? - MarketBeat
What is the dividend yield of Wave Life Sciences Ltd.Weekly Market Summary & Growth Focused Entry Reports - beatles.ru
683 Capital Management LLC Grows Stock Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Pulls Back 14% This Week, but Still Delivers Shareholders Strong 37% CAGR Over 3 Years - 富途牛牛
Short interest data insights for Wave Life Sciences Ltd.Weekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Risk adjusted return profile for Wave Life Sciences Ltd. analyzedWeekly Stock Recap & High Accuracy Trade Alerts - Newser
Published on: 2025-09-05 14:47:35 - Newser
Predicting Wave Life Sciences Ltd. trend using moving averages2025 Market Overview & Fast Moving Stock Trade Plans - Newser
B. Riley’s Strategic Acquisition of Wave Life Sciences: Capitalizing on Biotech Market Inefficiencies - AInvest
Using data tools to time your Wave Life Sciences Ltd. exitPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser
Relative strength of Wave Life Sciences Ltd. in sector analysisJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Wave Life Sciences Ltd. technicalsJuly 2025 Retail & Daily Stock Trend Reports - Newser
What indicators show strength in Wave Life Sciences Ltd.July 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Should you hold or exit Wave Life Sciences Ltd. nowDay Trade & AI Enhanced Execution Alerts - Newser
What’s the analyst consensus on Wave Life Sciences Ltd.Bond Market & Real-Time Volume Analysis Alerts - خودرو بانک
What is Wave Life Sciences Ltd.’s market position2025 Valuation Update & Weekly High Conviction Ideas - خودرو بانک
Wave Life Sciences Ltd. shares fall 1.19% intraday after a special call presentation. - AInvest
What does recent volatility data suggest for Wave Life Sciences Ltd.Market Performance Summary & Proven Capital Preservation Tips - Newser
WVE: Wells Fargo Lowers Price Target to $18, Maintains Overweigh - GuruFocus
Will Wave Life Sciences Ltd. rebound enough to break evenProfit Target & Free High Return Stock Watch Alerts - Newser
Wave Life Sciences stock price target lowered to $16 at Jones Trading - Investing.com Canada
Momentum divergence signals in Wave Life Sciences Ltd. chartWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Why Wave Life Sciences Ltd. is moving todayQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
WAVE Life Sciences stock maintains Outperform rating at Raymond James - Investing.com India
When is the best time to exit Wave Life Sciences Ltd.2025 Biggest Moves & Verified Entry Point Detection - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryWeekly Profit Analysis & Stock Portfolio Risk Management - Newser
Wave’s RNA editor gains proof of concept but not top positioning in AATD - biocentury.com
Will earnings trigger a reversal in Wave Life Sciences Ltd.Weekly Trade Report & Community Consensus Picks - Newser
WAVE Life Sciences stock maintains Outperform rating at Raymond James By Investing.com - Investing.com Australia
Wave Life says data are positive but stock wavers - BioWorld MedTech
Leerink Partners raises WAVE Life Sciences stock price target to $26 on AATD data - Investing.com
Assessing Wave Life Sciences' (WVE) RNA Editing Pipeline: Is the Stock Undervalued Amid Clinical Progress and Financial Challenges? - AInvest
Transcript : Wave Life Sciences Ltd.Special Call - MarketScreener
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? - Benzinga
WVE: HC Wainwright & Co. Reiterates Buy Rating with $22 PT | WVE Stock News - GuruFocus
Wave Life Sciences Shares Drop Following WVE-006 Trial Update - MSN
Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production - MarketScreener
Wave Life Sciences stock tumbles after WVE-006 trial update - Investing.com
Why Is Wave Life Sciences Stock (WVE) Down 20% Today? - TipRanks
Wave Life Sciences reports promising data for AATD treatment - Investing.com
Wave Life Sciences reports promising data for AATD treatment By Investing.com - Investing.com Australia
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Wave Life Sciences Ltd 주식 (WVE) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
자본화:
|
볼륨(24시간):